Showing results (1401-1410 of 5,257) with videos related to
Sort By:
Pageof 526
Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.Oncology|March 8, 2018
Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate CancerLi Rebekah Feng, Alexandra Espina, Leorey N SaliganOncology|January 1, 1988
Activity of epirubicin and dibromodulcitol in advanced breast cancer. Results of the South-East European Oncology Group StudyS Eckhardt, E Juhos, I Hindy, et al.Oncology|January 1, 1988
Diffuse well-differentiated lymphocytic lymphoma: chemotherapy with BCNU, cyclophosphamide, vincristine, melphalan and prednisoneD C Case, M Boyd, D M Hayes, et al.Oncology|January 1, 1988
A hypothesis concerning the relationship of cellular pharmakokinetics to optimal scheduling of anti-cancer agentsA J Weiss, R MantheiOncology|January 1, 1976
Effect of pyridoxine on the growth of Morris hepatoma No. 7288Ctc and enzyme activityG P TryfiatesOncology|January 1, 1991
Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the in vivo analysis of proliferative characteristics of human leukemia cells in bone marrowsS Nakamura, Y Takeda, M Kanno, et al.Oncology|December 14, 2006
Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patientsRiichiroh Maruyama, Ryuichi Suemitsu, Tatsuro Okamoto, et al.Oncology|March 23, 2007
Identification of VDR-responsive gene signatures in breast cancer cellsKelly Towsend, Victor Trevino, Francesco Falciani, et al.Oncology|March 8, 2007
Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinomaYuichi Hirasawa, Makoto Arai, Fumio Imazeki, et al.Pageof 526